Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: DBS – Is This the Time To Take Provision Expenses at 70% Lower than Average? and more

In today’s briefing:

  • DBS – Is This the Time To Take Provision Expenses at 70% Lower than Average?
  • Swire Prop 1972 HK: HK Office & China Retail Can Be Double Drag, No Share Buyback & Lack of Catalyst
  • Fancl: Not Out of the Woods Yet
  • Disney’s Q3 2023 Earnings: A Pivotal Quarter To Appease Investors And Analysts
  • PayPal: 3 Reasons Why I Am Optimistic After The Quarterly Results
  • Shofu (7979 JP) – Domestic Star Franchise Aiming for Global Center Stage
  • Glencore’s H1 Earnings: The Market’s Not Impressed
  • CLIQ Digital – Focusing on more profitable subscribers
  • AEye, Inc. – 2Q23 Revenue In Line with a Lower Loss
  • MariMed, Inc. – 2Q Revenue Expands While Adjusted EBITDA Declines


DBS – Is This the Time To Take Provision Expenses at 70% Lower than Average?

By Daniel Tabbush

  • There is no refuting the strong net interest income figures at DBS, although it seems toppy
  • DBS took credit costs/assets at 4bps in 2Q23 vs 13bps average during FY18, FY19 quarterly
  • There are not many banks that we can turn too with over 50% QoQ decline in credit costs

Swire Prop 1972 HK: HK Office & China Retail Can Be Double Drag, No Share Buyback & Lack of Catalyst

By Jacob Cheng

  • Swire Properties is one of the largest office and retail landlords in HK.  Office is facing headwind despite should see recovery in the long-term.  HK retail is recovering.
  • Swire announced to spend 100bn to expand its portfolio in terms of capital management, yet it did not announce a share buyback that many investors would like to see
  • Lack of share buyback, with weak HK office and China retail, could drag Swire’s share price.  Despite we see value in the stock, it could remain as value trap

Fancl: Not Out of the Woods Yet

By Oshadhi Kumarasiri

  • Fancl released 1QFY24 results last week. While revenue was broadly in line with consensus at ¥27.2bn (consensus ¥26.9bn), OP beat consensus by around 27% to generate an OP of ¥3.2bn.
  • While there were certain performance improvements in the flagship brands “FANCL” and “ATTENIR” during FQ1, there are no definitive signs that they are completely out of trouble.
  • Meanwhile, it looks like competition has affected Fancl Corp (4921 JP)’s plan to cut advertising costs. Thus, FY24 OP guidance could be under pressure.

Disney’s Q3 2023 Earnings: A Pivotal Quarter To Appease Investors And Analysts

By Vladimir Dimitrov, CFA

  • The main focus will remain on Direct-to-Consumer profitability, but areas such as the recently announced restructuring plan and pricing power in parks & experiences also deserve attention.
  • The main focus is on the company’s Direct- to- consumer profitability.
  • It has been three months since my latest update on The Walt Disney Company (NYSE:DIS) when I highlighted a number of reasons why the company is finally in a good position to deliver on its bottom line figures.

PayPal: 3 Reasons Why I Am Optimistic After The Quarterly Results

By Vladimir Dimitrov, CFA

  • PayPal stock has fallen dramatically on speculations regarding the near-term future.
  • The market is now pricing-in significant deterioration of the company’s top or bottom line.
  • The management is making the right moves to secure long-term competitive advantages, while also rewarding shareholders, according to the report.

Shofu (7979 JP) – Domestic Star Franchise Aiming for Global Center Stage

By Astris Advisory Japan

  • From a niche player to a global high-flyer – Shofu is a domestic market leader in developing and manufacturing dental materials and equipment.

  • With its proprietary technology and expertise, it is aiming to become a global top 10 player with a strategic focus on overseas expansion.

  • With an addressable market estimated to become up to 20 times larger than Japan, growth prospects are high and the company is gaining solid traction with FY3/2023 results set to reach record highs.


Glencore’s H1 Earnings: The Market’s Not Impressed

By Pearl Gray Equity and Research

  • Glencore plc’s first half earnings landed softer than most of its shareholders would’ve liked.
  • We think a period of stability is near, but key indicators fail to suggest the miner is set for a steep recovery.
  • Mining powerhouse, Glencore plc (OTCPK:GLCNF) released its first-half earnings results on Tuesday and delivered a few surprises by doing so.

CLIQ Digital – Focusing on more profitable subscribers

By Edison Investment Research

CLIQ Digital delivered robust growth in H123, with 37% year-on-year growth in both revenue and EBITDA at a maintained margin of 15.8%. Growth continues to be driven by growing marketing spend and investment into evolving the bundled content offering. Given a more competitive bidding market, management is focusing on acquiring customers with a higher lifetime value to create a more profitable subscriber base. Management has reiterated both its FY23 and mid-term FY25 guidance and our headline forecasts remain unchanged. Despite CLIQ’s share price performance faring better than the peer average valuation, it remains at a significant discount to peers on both EV/sales and EV/EBITDA multiples. In our view there continues to be significant upside to the current share price on our current estimates.


AEye, Inc. – 2Q23 Revenue In Line with a Lower Loss

By Water Tower Research

  • 2Q23 revenue came in as expected at $0.6 million, while EPS was slightly better than expected at a loss of $0.07 versus consensus of a loss of $0.09.

  • CEO Matt Fisch said that the company has “taken a significant step forward this quarter in our path to commercialization in the automotive market” and “achieved major in-vehicle test milestones with three prestigious industry players, including NVIDIA and two global automotive OEMs.”

  • AEye’s progress with automotive RFQs (two finalists with four more RFQs in progress) has been based on its product’s performance and cost. 


MariMed, Inc. – 2Q Revenue Expands While Adjusted EBITDA Declines

By Water Tower Research

  • MariMed reported second-quarter revenue of $36.5 million, which was modestly ahead of our estimate of $36.0 million.

  • This is a 10.6% Y/Y increase in revenue and a 6.2% improvement Q/Q.

  • Higher revenue was driven by the opening of the adult-use Panacea Wellness Store in Beverly Massachusetts on April 25 and the Thrive Wellness medical dispensary in Tiffin, Ohio that opened on June 12. During 2Q, MariMed also benefited from its recent approval to begin manufacturing and selling high- dose edibles in Maryland.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars